Success Metrics

Active Trials
8(89%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_3
8
89%

Phase Distribution

1

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
8(88.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

8

trials recruiting

Total Trials

9

all time

Status Distribution
Active(9)

Detailed Status

Recruiting8
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
8
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 11 (11.1%)
Phase 38 (88.9%)

Trials by Status

recruiting889%
not_yet_recruiting111%

Recent Activity

Clinical Trials (9)

Showing 9 of 9 trials
NCT07571005Phase 3

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Recruiting
NCT07571109Phase 3

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Recruiting
NCT07533175Phase 3

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Recruiting
NCT07503210Phase 3

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

Recruiting
NCT07509307Phase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Recruiting
NCT07481630Phase 3

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Recruiting
NCT07339423Phase 3

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Recruiting
NCT07508020Phase 1

A Research Study Looking at How NNC0487-0111 Affects Food Intake, Appetite and Metabolism After Meals in People With Obesity

Recruiting
NCT07400107Phase 3

AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Not Yet Recruiting

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9